Price
$0.04
Decreased by -13.76%
Dollar volume (20D)
382.69
ADR%
8.16
Shares float
18.77 M
Shares short
19.00 K [0.10%]
Shares outstanding
0.00
Market cap
N/A
Beta
4.89
Price/earnings
N/A
20D range
0.03 0.05
50D range
0.09 0.28

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease.

It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.

Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 23 10.03 K
Increased by +N/A%
-1.93 M
Decreased by -67.91%
Decreased by -19.27 K%
Decreased by N/A%
Jun 30, 23 1.73 K
Increased by +N/A%
-4.02 M
Decreased by -377.78%
Decreased by -233.21 K%
Decreased by N/A%
Mar 31, 23 0.00
Decreased by N/A%
-1.03 M
Decreased by -256.01%
Decreased by N/A%
Decreased by N/A%
Dec 31, 22 950.00
Increased by +N/A%
-2.38 M
Decreased by -2.39 K%
Decreased by -250.32 K%
-
Sep 30, 22 0.00
Decreased by N/A%
-1.15 M
Decreased by -720.46%
Decreased by N/A%
-
Jun 30, 22 0.00 - -842.00 K -
Decreased by N/A%
-
Mar 31, 22 0.00 - -290.06 K -
Decreased by N/A%
-
Jun 30, 21 N/A - -95.45 K - - -
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY